Accepted for Publication: April 22, 2021.
Published: July 15, 2021. doi:10.1001/jamanetworkopen.2021.14741
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Ohl ME et al. JAMA Network Open.
Corresponding Author: Michael E. Ohl, MD, MSPH, Department of Internal Medicine, Carver College of Medicine, University of Iowa, 200 Hawkins Drive, SW34 GH, Iowa City, IA 52242 (email@example.com).
Author Contributions: Drs Ohl and Vaughan Sarrazin had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Ohl, Miller, Lund, Kobayashi, Crothers.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Ohl, Kobayashi, Richardson Miell, Alexander, Vaughan Sarrazin.
Critical revision of the manuscript for important intellectual content: Ohl, Miller, Lund, Kobayashi, Richardson Miell, Beck, Crothers, Vaughan Sarrazin.
Statistical analysis: Miller, Kobayashi, Vaughan Sarrazin.
Obtained funding: Ohl, Miller.
Administrative, technical, or material support: Miller, Lund, Richardson Miell.
Supervision: Lund, Richardson Miell, Vaughan Sarrazin.
Conflict of Interest Disclosures: Dr Ohl reported receiving grants from Veterans Affairs Health Services Research and Development during the conduct of the study and consulting for Gilead Pharmaceuticals outside the submitted work. Dr Lund reported receiving grants from the US Department of Veterans Affairs during the conduct of the study. Mr Beck reported receiving grants from the Veterans Health Administration during the conduct of the study. Dr Alexander reported receiving grants from the US Department of Veterans Affairs during the conduct of the study and serving as a contract data manager for the Iowa City Veterans Affairs Medical Center Research Department outside the submitted work. No other disclosures were reported.
Funding/Support: This study was supported by award C19-20-404 from the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (Dr Ohl).
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The views expressed herein are those of the authors and do not necessarily reflect the views of the US Department of Veterans Affairs.
Additional Contributions: Michihiko Goto, MD, MS, and Cassie Goedken, MPH, Center for Access & Delivery Research and Evaluation, Iowa City Veterans Affairs, provided assistance with the production of tables and figures and did not receive compensation.
ML , Andres
EL , Sims
et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio
. 2018;9(2):e00221-18. doi:10.1128/mBio.00221-18
H , Peto
R , Henao-Restrepo AM,
et al; WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19—interim WHO Solidarity Trial results. N Engl J Med.
2021;384(6):497-511. doi:10.1056/NEJMoa2023184PubMedGoogle Scholar
CD , Gottlieb
RL , Criner
et al; GS-US-540-5774 Investigators. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA
. 2020;324(11):1048-1057. doi:10.1001/jama.2020.16349
E , Altman
DG , Egger
M , Pocock
SJ , Gøtzsche
PC , Vandenbroucke
JP ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet
. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X
P , Lim
WS , Emberson
JR , et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med
. 2021;384(8):693-704. doi:10.1056/NEJMoa2021436PubMedGoogle Scholar
PC . Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med
. 2009;28(25):3083-3107. doi:10.1002/sim.3697
MR , Bach
PB , Baldwin
MR . Hospital length of stay for patients with severe COVID-19: implications for remdesivir’s value. Pharmacoecon Open
. 2021;5(1):129-131. doi:10.1007/s41669-020-00243-6